Main event Oslo Life Science 2020: Life sciences in the next decade

Welcome to the Oslo Life Science Conference 5-year anniversary where we look ahead into the new decade. What will life sciences bring us in 2020–2030? What is the role of artificial intelligence (AI)? What are the visions for academia, hospitals and industry in a rapidly changing world where we need sustainable solutions? How can Oslo and Norway strengthen its position as a leading life science hub in Europe?

Banner main event Oslo Life Science 2020

Target groups: researchers, students, bureaucrats, businesspeople, investors and politicians. 

Reception hosted by the City of Oslo in Oslo City Hall after the main event.

Sign up for the main event and the reception

The doors open at 14.00. The programme starts at 14.30.

Programme with speakers and tentative titles for their talks

Session 1: Welcome and the importance of AI and Horizon Europe for life sciences in the next decade

Paul ChaffeyOpening speech – value creation through digitalisation in life sciences – how to utilise Norwegian advantages

Paul Chaffey, State Secretary to the Minister of Digitalisation (Conservative Party)



Welcome – visions for life science research, education and innovation at UiO and the importance of the new life science building that is ready for use in 2024

Svein Stølen, PhD

Rector, UiO


How to use AI to improve patient care and accelerating medical research

Rabia Khan, PhD MBA

Chief of Translational Medicine, Sensyne Health, UK



Faster and safer cancer prognostics with AI

Håvard E. Danielsen, PhD

Professor, Department of Informatics, UiO; Director, Institute for Cancer Genetics and Informatics, Oslo University Hospital; and PI in the DoMore! project


Improving AI with cutting edge brain research – an interdisciplinary approach

Marianne Fyhn, PhD

Professor, Department of Biosciences, UiO; leader of Centre for Integrative Neuroplasticity (CINPLA); and member of the UiO:Life Science convergence environment MultiModal Mental Models (4MENT)


How to prepare for Horizon Europe – the €100 billion next EU research and innovation framework programme 2021–2027? The ERC in EU Framework Programmes: bringing value from bottom-up research in life sciences

Philippe Cupers, PhD

Head of the Life Sciences unit (ERCEA.B.3), European Research Council (ERC) Executive Agency


Session 2: Value creation in life sciences and collaboration across disciplines and sectors in the next decade

New opportunities for collaboration between big pharma and academia in White City Campus in London – a role model for Oslo Science City?

Mark Toms, Dr.

Medical Director & Chief Scientific Officer, Novartis UK


The need for innovation in health care – success stories and success factors and opportunities at BII also for Oslo-based researchers and entrepreneurs

Hervør Lykke Olsen, PhD

Senior business developer, BioInnovation Institute (BII), Denmark


New trends in innovation and collaboration in health-related and environmental life sciences – why are Nordic actors attractive partners for Fraunhofer?

Claus-Dieter Kroggel, PhD

Head of Central Office, Fraunhofer Group for Life Sciences, Germany


Pitches from UiO:Life Science's convergence environments, projects in UiO:Life Science's innovation programme for health related life sciences SPARK Norway and industry in Oslo

Future models for diabetes research by using new strategies for stem cell differentiation – collaboration between medicine, musicology and physics

Hanne Scholz, PhD

Leader of the convergence environment Artificial Biomimetic systems – the Niche of Islet Organoids (ABINO), PI in the convergence environment Organ on a chip and Vice Director of the Centre of Excellence Hybrid Technology Hub

Empowering cancer immunotherapy with AI

Jenny-Ann Malmberg, PhD

Software Development Manager, NEC Oncoimmunity


The list of pitches will be completed after the new projects in have been admitted to UiO:Life Science's innovation programme SPARK Norway 31 January 2020.

Session 3: The future of Oslo as a life science hub

Conversation between Carl Henrik Gørbitz, director of UiO:Life Science, and the new UiO:Life Science Strategic Advisory Board (SAB). We will get their interdisciplinary perspectives on what they have heard throughout the event and how they see Oslo as a hub for life science-related activities in the years to come. Members of the SAB:

  • Sirpa Jalkanen, Professor of Immunology, Academician, Director of MediCity, University of Turku, Finland
  • Jari Koistinaho, Director of Neuroscience Center, Helsinki Institute of Life Science, University of Helsinki and Professor of Regenerative Medicine, University of Eastern Finland
  • Melissa Parker, Professor of Medical Anthropology, Department of Global Health and Development, London School of Hygiene and Tropical Medicine
  • Laurence D. Hurst, Professor of Evolutionary Genetics and Director of the Milner Centre for Evolution Department of Biology and Biochemistry, The University of Bath

19.00 Reception hosted by the City of Oslo in Oslo City Hall

Sign up for the main event and the reception

Pictures and videos from the main event in 2019

Swipe on the arrows on the pictures in the image carousel below. Links to videos in the caption for each picture. 

Pictures from main event on health industry, Oslo Life Science 2019

Published Nov. 18, 2019 2:35 PM - Last modified Jan. 18, 2020 1:27 PM